- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pexastimogene Devacirepvec (Pexa Vec)
Total 21 results
-
SillaJen, Inc.Regeneron PharmaceuticalsActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Korea, Republic of
-
National Cancer Institute (NCI)CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Carcinoma | Colorectal Adenocarcinoma | Refractory CancerUnited States
-
TransgeneTerminated
-
SillaJen, Inc.CompletedHepatocellular Carcinoma (HCC)United States, Canada, New Zealand, Australia, China, France, Germany, Hong Kong, Israel, Italy, Korea, Republic of, Portugal, Singapore, Taiwan, Thailand, United Kingdom
-
Lee's Pharmaceutical LimitedRecruitingLocal Progression or Metastatic Melanoma With Failed First-line TreatmentChina
-
Jennerex BiotherapeuticsSolving Kids' CancerCompletedLymphoma | Neuroblastoma | Rhabdomyosarcoma | Wilm's Tumor | Ewing's SarcomaUnited States
-
Centre Leon BerardTransgeneCompletedAdvanced Tumor | Metastatic TumorFrance
-
Erasmus Medical CenterNot yet recruiting
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bFinland, Italy
-
Institut BergoniéMerck Sharp & Dohme LLC; National Cancer Institute, France; Transgene; Fondation...RecruitingBreast Cancer | Soft-tissue Sarcoma | Solid TumorsFrance
-
GlaxoSmithKlineKwame Nkrumah University of Science and Technology; European & Developing Countries... and other collaboratorsRecruiting
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
GlaxoSmithKlineRecruiting
-
Abdullah KhanRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Elvira UmyarovaSanofiRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsUnited States
-
National Cancer Institute (NCI)WithdrawnT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage